One size does not fit all in Asia value creation – AVCJ Forum
Replacing portfolio company CEOs is not part of buyout firms’ value creation playbook in emerging markets, the AVCJ Private Equity & Venture Forum heard.
Gaurav Sharma, head of private equity India of Investcorp, said that bringing in an operational partner who had been a professional CEO didn’t work for his firm. What worked was bringing in an independent...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.